Immunohistochemistry on a Panel of Emery-Dreifuss Muscular Dystrophy Samples Reveals Nuclear Envelope Proteins as Inconsistent Markers for Pathology

Phú Lê Thành, Peter Meinke, Nadia Korfali, Vlastimil Srsen, Michael Robson, Manfred Wehnert, Benedikt Schoser, Caroline Sewry, Eric Schirmer

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Reports of aberrant distribution for some nuclear envelope proteins in cells expressing a few Emery-Dreifuss muscular dystrophy mutations raised the possibility that such protein redistribution could underlie pathology and/or be diagnostic. However, this disorder is linked to 8 different genes encoding nuclear envelope proteins, raising the question of whether a particular protein is most relevant. Therefore, myoblast/fibroblast cultures from biopsy and tissue sections from a panel of nine Emery-Dreifuss muscular dystrophy patients (4 male, 5 female) including those carrying emerin and FHL1 (X-linked) and several lamin A (autosomal dominant) mutations were stained for the proteins linked to the disorder. As tissue-specific nuclear envelope proteins have been postulated to mediate the tissue-specific pathologies of different nuclear envelopathies, patient samples were also stained for several muscle-specific nuclear membrane proteins. Although linked proteins nesprin 1 and SUN2 and muscle-specific proteins NET5/Samp1 and Tmem214 yielded aberrant distributions in individual patient cells, none exhibited defects through the larger patient panel. Musclespecific Tmem38A normally appeared in both the nuclear envelope and sarcoplasmic reticulum, but most patient samples exhibited a moderate redistribution favouring the sarcoplasmic reticulum. The absence of striking uniform defects in nuclear envelope protein distribution indicates that such staining will be unavailing for general diagnostics, though it remains possible that specific mutations exhibiting protein distribution defects might reflect a particular clinical variant. These findings further argue that multiple pathways can lead to the generally similar pathologies of this disorder while at the same time the different cellular phenotypes observed possibly may help explain the considerable clinical variation of EDMD.
Altered distribution of EDMD-linked proteins is not a general characteristic of EDMD
Tissue-specific proteins exhibit altered distributions in some
EDMD patients Variation in redistributed proteins in EDMD may underlie its clinical variability
Original languageEnglish
JournalNeuromuscular Disorders
Early online date21 Dec 2016
Publication statusPublished - Apr 2017

Keywords / Materials (for Non-textual outputs)

  • Emery-Dreifuss muscular dystrophy
  • nuclear envelope
  • muscle biopsy
  • Nuclear envelope transmembrane protein


Dive into the research topics of 'Immunohistochemistry on a Panel of Emery-Dreifuss Muscular Dystrophy Samples Reveals Nuclear Envelope Proteins as Inconsistent Markers for Pathology'. Together they form a unique fingerprint.

Cite this